Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients

Figure 5

ECT2 affecting 5-FU sensitivity in GC cells by regulating cell viability, metastasis, and apoptosis-related proteins.